Immunome (IMNM) Change in Acquisitions & Divestments (2024 - 2025)

Immunome (IMNM) reported Change in Acquisitions & Divestments of $125.0 million for Q3 2025, up 316.67% on a YoY basis from $30.0 million in Q3 2024, and up 108.33% quarter-over-quarter from $60.0 million in Q2 2025.

Immunome (IMNM) Change in Acquisitions & Divestments (2024 - 2025) Analysis & Trends

Immunome has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $125.0 million in Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 316.67% year-over-year to $125.0 million; the trailing twelve-month figure through Mar 2026 stood at $185.0 million (changed N/A YoY), and the FY2025 full-year result was $200.0 million, up 29.03% from the prior year.
  • Change in Acquisitions & Divestments for Q3 2025 stood at $125.0 million, up from $60.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $125.0 million in Q3 2025, with the low at $15.0 million in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Immunome 2.12 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 125.00 Mn
Sep 30, 2025 125.00 Mn
Jun 30, 2025 60.00 Mn
Jun 30, 2025 60.00 Mn
Mar 31, 2025 15.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 85.00 Mn
Dec 31, 2024 85.00 Mn
Sep 30, 2024 30.00 Mn
Sep 30, 2024 30.00 Mn